School of Medicine
Showing 8,501-8,600 of 12,980 Results
-
Pritam Kumar Panda
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsDr. Panda’s current research at Stanford University School of Medicine centers on the innovative design of anesthetics optimized for battlefield application. His work integrates advanced methodologies such as AI-driven protein design, molecular dynamics simulations, and computational drug design to identify and model potential anesthetic compounds with precision and efficacy.
-
Vijay Pande
Adjunct Professor, Structural Biology Department
BioVijay Pande, Henry Dreyfus Professor of Chemistry and, by courtesy, of Structural Biology and Computer Science, also currently directs of the Stanford Program in Biophysics and the Folding@home Distribtued Computing project. His research centers on novel cloud computing simulation techniques to address problems in chemical biology. In particular, he has pioneered distributed computing methodology to break fundamental barriers in the simulation of protein and nucleic acid kinetics and thermodynamics. As director of the Folding@home project (http://folding.stanford.edu), Prof. Pande has, for the first time, directly simulated protein folding dynamics, making quantitative comparisons with experimental results, often considered a “holy grail” of computational biology. His current research also includes novel computational methods for drug design, especially in the area of protein misfolding and associated diseases such as Alzheimer’s and Huntington’s Disease.
Professor Pande studied physics at Princeton University (B.A. 1992), where he was first introduced to biophysical questions, especially in undergraduate research with Nobel Laureate P. Anderson. His doctoral research in physics under Profs. T. Tanaka and A. Grosberg at MIT (Ph.D. 1995) centered on statistical mechanical models of protein folding, suggesting new ways to design protein sequences for stability and folding properties. As a Miller Fellow under Prof. D. Rokhsar at UC Berkeley, Prof. Pande extended this methodology to examine atomistic protein models, laying the foundations for his work at Stanford University. Among numerous awards, Prof. Pande has received the Biophysical Society’s Bárány Award for Young Investigators and Protein Society’s Irving Sigal Young Investigator Award, and was named to MIT’s TR100 and elected a Fellow of the American Physical Society.
The Pande research group develops and applies new theoretical methods to understand the physical properties of biological molecules such as proteins, nucleic acids and lipid membranes, using this understanding to design synthetic systems including small-molecule therapeutics. In particular, the group examines the self-assembly properties of biomolecules. For example, how do protein and RNA molecules fold? How do proteins misfold and aggregate? How can we use this understanding to tackle misfolding related degeneration and develop small molecules to inhibit disease processes?
As these phenomena are complex, spanning molecular to mesoscopic lengths and nanosecond to millisecond timescales, the lab employs a variety of methods, including statistical mechanical analytic models, Markov State Models, and statistical and informatic methods. Other tools include Monte Carlo, Langevin dynamics, and molecular dynamics computer simulations on workstations and massively parallel supercomputers, superclusters, and worldwide distributed computing. The group has also done extensive work in the application of machine learning, pioneering traditional and deep learning approaches to cheminformatics, biophysics and drug design.
For example, simulations in all-atom detail on experimentally relevant timescales (milliseconds to seconds) have produced specific predictions of the structural and physical chemical nature of protein aggregation involved in Alzheimer’s and Huntington’s diseases. These results have fed into computational small molecule drug design methods, yielding interesting new chemical entities.
Since such problems are extremely computationally demanding, the group developed a distributed computing project for protein folding dynamics. Since its launch in October 2000, Folding@Home has attracted more than 4,000,000 PCs, and today is recognized as the most powerful supercluster in the world. Such enormous computational resources have allowed simulations of unprecedented folding timescales and statistical precision and accuracy. For more details, please visit http://pande.stanford.edu. -
Mahesh Pandit
Postdoctoral Scholar, Immunology and Rheumatology
BioI have completed my PhD in Immunology from Yeungnam University, South Korea. I studied adaptive immune cells especially focusing T cells and its relation to autoimmunity and tumor. I worked on different conditional knockout mice to investigate the cellular mechanisms. Similarly, I worked on disease induced mice to study its preventive and therapeutic approaches. Currently, I am working on Translational immunology as a Postdoctoral Researcher at Stanford University department of Immunology and Rheumatology. I focus on Epstein-Barr Virus, B cells and its relation with various autoimmune diseases.
-
Danielle Mari Panelli
Assistant Professor of Obstetrics and Gynecology (Maternal Fetal Medicine and Obstetrics)
BioDr. Danielle Panelli, MD, MS is an Instructor in Maternal–Fetal Medicine in the Department of Obstetrics and Gynecology at Stanford University School of Medicine. She completed Ob/Gyn residency training at Harvard (Brigham and Women’s Hospital/Mass General Hospital), and both fellowship training in Maternal–Fetal Medicine and a Masters Degree in Epidemiology and Clinical Research at Stanford.
Dr. Panelli is a clinician–scientist whose work bridges clinical and translational research to understand how stress and mental health shape pregnancy outcomes and postpartum recovery. Her research program focuses on psychobiologic markers of stress—including telomere dynamics and epigenetic aging—to advance precision medicine approaches for perinatal mental illness and pregnancy complications.
Clinically, she cares for routine and high-risk obstetric patients and integrates trauma-informed, evidence-based approaches into care delivery. She is committed to mentorship and education, serves as Director of Research for the Maternal–Fetal Medicine Fellowship, and contributes to national leadership and scholarship in perinatal mental health. -
Anil K. Panigrahi
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor (By courtesy), PathologyBioAnil K. Panigrahi, MD, PhD, FASA is a Clinical Associate Professor in the Departments of Anesthesiology and, by courtesy, Pathology at Stanford University School of Medicine. Dual board-certified in Anesthesiology and Blood Banking/Transfusion Medicine, he maintains active clinical practice in both fields. He serves as Director of Patient Blood Management at Stanford Health Care, Chair of the Stanford Health Care Transfusion Committee, Medical Director of the Anesthesiology Perioperative Anemia Management Clinic, and Assistant Medical Director of the Stanford Health Care Transfusion Service. His academic and clinical leadership focuses on advancing perioperative blood management strategies to optimize outcomes in complex surgical patients.
A Phi Beta Kappa graduate of Duke University, Dr. Panigrahi received his M.D. and Ph.D. degrees from the University of Pennsylvania School of Medicine, where he was awarded the John G. Clark Prize for meritorious research. He completed residency training in Anesthesiology and fellowship in Blood Banking/Transfusion Medicine at Stanford University.
Dr. Panigrahi’s scholarly work spans immunology, transfusion safety, and patient blood management. He has authored numerous peer-reviewed publications, textbook chapters, including for Miller’s Anesthesia and the AABB Technical Manual, and national guidelines. He contributes nationally through service on multiple committees for the American Society of Anesthesiologists (ASA) and the Association for the Advancement of Blood and Biotherapies (AABB), and he is a frequent invited speaker at national and international meetings, including those of the ASA, AABB, and Society for the Advancement of Patient Blood Management (SABM). -
Heather Ryan Pankow
Life Science Rsch Prof 2, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordLife Science Research Professional 2 in The Depression Research Clinic
-
Lori D Panu
Sr. Program Manager, Clinical Research Operations, Med/Stanford Center for Clinical Research
Current Role at StanfordSr. Program Manager, Clinical Research Operations
-
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
-
Sara Pardej
Postdoctoral Scholar, Psychiatry
BioSara Pardej earned her BA in Psychology and BS in Cognitive Science at Marquette University. Afterwards, she attended the Clinical Psychology Doctoral Program at the University of Wisconsin-Milwaukee under the mentorship of Dr. Bonita P. Klein-Tasman, where she earned both her MS and PhD in Clinical Psychology. There, she worked on several studies focusing on youth with neurofibromatosis type 1 (NF1), including behavioral phenotyping work, psychometric studies, and a social skills intervention study. Her dissertation study, which was funded by a Young Investigator Award from the Children's Tumor Foundation, focused on examining event related potentials using EEG by comparing children with NF1 to children with idiopathic ADHD and unaffected children. She completed her Doctoral Internship in Clinical Psychology at Penn State Health in Hershey, Pennsylvania. While at Penn State, she also worked on research examining safety and psychopathology in youth with ADHD and/or autism. Her clinical interest is neuropsychology, and her research interests include issues of psychometrics, behavioral phenotyping, and the neuropsychological development (and subsequent areas of intervention) of individuals with NF1 across the lifespan.
-
Vedant Pargaonkar
Basic Life Research Scientist, Medicine - Med/Cardiovascular Medicine
BioMy long-term research interests involve development of algorithms using computational methods for early detection of coronary pathophysiology including, endothelial dysfunction and microvascular dysfunction (MVD) and/or a myocardial bridge (MB) in patients with angina and no obstructive coronary artery disease (NOCAD) and the identification of novel target therapies for primary prevention and improved prognosis in these patients. Under the mentorship of Dr. Jennifer Tremmel in Cardiovascular medicine at Stanford, I have been systematically studying to better understand the underlying pathophysiology of these patients, as well as the optimal use of diagnostic testing and treatment using the angina and no-obstructive CAD Registry at Stanford. In collaboration with other investigators in this field, we have published multiple scientific articles highlighting the limitations of current testing in this population and identification of novel diagnostic tools for early diagnosis and management of patients with angina and no obstructive CAD. My research also focuses on myocardial infarction (MI) in women, particularly spontaneous coronary artery dissection (SCAD). I have been involved in the design and execution of the first international collaborative study in SCAD, investigating peripartum vs. non-peripartum SCAD. This is analyzing the largest cohort of patients recruited from multiple US and non-US sites to understand the pathophysiological differences in these patient cohorts.
-
Peter Parham
Professor of Structural Biology and, by courtesy, of Microbiology and Immunology
On Leave from 03/16/2026 To 07/05/2026Current Research and Scholarly InterestsThe Parham laboratory investigates the biology, genetics, and evolution of MHC class I molecules and NK cell receptors.
-
Mitchel Pariani
Clinical Assistant Professor (Affiliated), Pediatrics - Genetics
BioMitchel earned his Master’s degree in genetic counseling from California State University, Northridge in 2007. At Cedars-Sinai Medical Center Mitchel served as genetic counselor and coordinator for David Rimoin, MD, PhD’s connective tissue disorders clinic and later established the cardiovascular genetics program at CSMC. At CSMC he also created the CSMC Summer Genetic Counseling Rotation Program that hosted students from genetic counseling programs around the United States. In 2014 he joined the new Stanford Center for Inherited Cardiovascular Disease to start a familial hypercholesterolemia clinic and provide genetic counseling for patients with cardiomyopathies. As the center expanded, Mitchel joined the Stanford Marfan Center as a genetic counselor and serves as program coordinator. He is the primary instructor for Stanford’s Cardiovascular Genetics course and serves as a clinical supervisor and mentor for students and volunteers.
-
Divya Parikh, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University.
Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.
Dr. Parikh has a strong research background. She has published in multiple academic journals and presented her findings through poster and oral presentations at various medical conferences. -
Victoria Parikh, MD
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.
Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. -
David J. Park, MD, PhD, FCNS
Clinical Assistant Professor, Neurosurgery
Current Research and Scholarly InterestsThe goal of our Laboratory is to improve patients’ care and outcomes by analyzing clinical data from thousands of patients treated at our institution. Our current primary areas of interest are benign tumors, brain and spine metastases, and neurogenetic disorders.
Our lab is led by Dr. Steven D. Chang and Dr. David J. Park and proudly hosts talented young clinical scientists from around the world.
Link: https://med.stanford.edu/neurosurgery/research/NeuroOncLab.html -
Eunkyung Angela Park, MD, PhD
Clinical Associate Professor, Radiology - Rad/Nuclear Medicine
BioDr. Eunkyung Angela Park is a Clinical Associate Professor (affiliated) at the Department of Radiology at Stanford and Nuclear Medicine Staff Physician at Palo Alto VA Medical Center. She takes care of patients having cancer, various diseases in the brain, heart and other organs through molecular imaging and targeted radiopharmaceutical therapies. Dr. Park graduated from Seoul National University College of Medicine and completed clinical and research training at Seoul National University Hospital, Yale University PET Center, University of Iowa Hospitals and Clinics. She served as Associate Section Chief in Nuclear Medicine at University of Utah before joining Stanford. Her main professional interests include global promotion of nuclear medicine, clinical/translational research in nuclear neurology, and operational system innovation. Dr. Park is particularly interested in early and accurate differential diagnoses of mixed neurodegenerative disorders by using brain PET imaging with various radiopharmaceuticals targeting glucose metabolism, amyloid, tau, neuroreceptors and transporters. She enjoys traveling, practicing yoga, playing tennis and anything about music.
-
Jon Park, MD, FRCSC
Saunders Family Professor
Current Research and Scholarly InterestsNon-fusion dynamic spinal stabilization, artificial disc technologies, and regenerative spinal technologies.
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Cyclotron and radiochemstry facility in 2014. I focus on routine radiopharmaceutical production, including 18F tracers (18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F Arag, 18F-FSPG etc.); 11C tracers (11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713 etc.); 15O-H2O and 68Ga-DOTATATE radiochemistry for clinical use and supporting various of pre-clinical studies.
-
Junyoung Park
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Jun Young graduated from the Department of Biostatistics at the School of Public Health, Seoul National University, Korea. His major field of study is biostatistics, with a specific focus on the application of machine learning and statistical analysis to medical imaging and genetic data. During his doctoral studies, he concentrated on two primary research areas. Firstly, he dedicated himself to the development of deep learning models for medical images, primarily centered on T1-MRI and cognitive function test images related to Alzheimer's Disease. Secondly, he engaged in extensive genome-wide association analyses of medical images associated with Alzheimer's Disease, using statistical algorithms to uncover novel insights into the genetic factors contributing to this complex condition. Currently, as a postdoctoral fellow at the Greicius Lab at Stanford, he aims to develop statistical methods to discover novel structural variants and model polygenetic risk scores using long-read sequencing data.
-
KT Park MD MS
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.
-
Lesley Park
Senior Research Scientist, Epidemiology and Population Health
BioStanford Advancing Health Equity and Diversity (AHEaD)
ahead.stanford.edu
Founding Co-Director (2020-present)
Veterans Aging Cohort Study (VACS)
Executive Director (2022-present)
Cancer Core Co-Director (2016-present)
International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
iwhod.org
Chair, Scientific Secretariat (2024-present)
Dr. Lesley Park is a co-founding director of the Stanford AHEaD summer research program for college students from underrepresented and historically excluded groups in the health sciences. She is also the Executive Director of the VACS consortium, an international collaboration of methodologists, clinicians, and trainees who utilize the rich and valuable data from the Veterans Health Administration to do impactful research. VACS has been at the forefront of research to understand aging with HIV to improve patient care, particularly with respect to alcohol and other substance use, physiologic frailty, and polypharmacy. In recent years, the VACS mission has expanded to encompass other foci, including genomic research and most recently COVID-19.
Within the VACS, Dr. Park oversees cancer and COVID-19 outcomes research in persons with HIV/AIDS (PWH). Her research experience has focused on the intersection of cancer and HIV, examining epidemiologic methods for cancer research, cancer incidence trends, and cancer (particularly hepatocellular carcinoma) prevention in PWH. Dr. Park is an experienced epidemiologist, skilled in "big data" observational research, survival analysis, and SAS programming. She teaches courses in computing, data management, and epidemiologic analysis methods. Her prior experience includes research at the Yale School of Medicine and at the Center for Biostatistics in AIDS Research (CBAR) at the Harvard School of Public Health.
The International Workshop on HIV and Hepatitis Observational Databases (IWHOD) is an established scientific forum for the appropriate application of real-world data to emerging issues in infectious disease. Dr. Park leads the IWHOD scientific committee of internationally reknowned experts in infectious disease and is responsible for administrative and scientific coordination of IWHOD.
Previously, Dr. Park was one of the leaders of the Stanford Center for Population Health Sciences (PHS). PHS aims to improve the health of populations by bringing together diverse disciplines and data to understand and address social, environmental, behavioral, and biological factors. She oversaw all of the educational and training initiatives at PHS and was one of the founding directors of the PHS Data Center and PHS Postdoctoral Fellowship program. -
Namu Park
Postdoctoral Scholar, Biomedical Informatics
BioDr. Park is a Postdoctoral Scholar at the Division of Computational Medicine at Stanford University, where he is co-advised by Dr. Tina Hernandez-Boussard and Dr. Yair Bannet. He received his PhD in Biomedical and Health Informatics from the University of Washington.
His research focuses on clinical natural language processing and large language models for healthcare. He develops clinically grounded information extraction methods and evaluation frameworks that reflect real-world clinical workflows. His work examines how large language models can be aligned with clinical reasoning and rigorously evaluated for safe and effective deployment in health systems.
Through interdisciplinary collaboration, Dr. Park aims to bridge advances in foundation models with measurable clinical impact, emphasizing reliability, transparency, and scalability in AI-driven healthcare applications. -
Walter Park
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
-
Karen J. Parker, PhD
Truong-Tan Broadcom Endowed Professor and Professor, by courtesy, of Comparative Medicine
Current Research and Scholarly InterestsThe Parker Lab conducts research on the biology of social functioning in monkeys, typically developing humans, and patients with social difficulties.
-
Robertson Parkman
Other Teaching Staff-Hourly, Pediatrics - Stem Cell Transplantation
BioMy principal research interests have been the assessment of the immunological consequences of hematopoietic stem cell transplantation including both acute and chronic graft versus host disease and immune reconstitution and the use of hematopoietic stem cell transplantation to treat genetic diseases. My laboratory was the first to suggest that chronic graft versus host disease was an autoimmune disease directed at histocompatibility antigens shared by donors and recipients. The observation leaded to the assessment of the role of thymic dysfunction in the pathogenesis of chronic graft versus host disease. As a pediatric immunologist I have investigated the role of hematopoietic stem cell transplantation initially in the treatment of primary immune deficiency diseases and later the treatment of metabolic diseases, which lead to my involvement in the early gene transfer clinical trials.
-
Ugur Parlatan
Basic Life Research Scientist, Rad/Canary Center at Stanford for Cancer Early Detection
BioDr. Ugur Parlatan is a Basic Life Research Scientist at the Canary Center at Stanford for Cancer Early Detection. Trained as a physicist, he leads photonics laboratory activities and develops optical spectroscopy and imaging approaches for molecular fingerprinting and characterization of extracellular vesicles (EVs). His work includes designing and optimizing measurement workflows, analyzing EV signatures from biomedical samples, and supporting disease-focused studies across cancer and metabolic conditions (including lung cancer, glioblastoma, pancreatic cancer, diabetes, and hepatotoxicity). He also mentors trainees (including NIH CREST program interns) and contributes to manuscripts and grant applications.
-
Jane Parnes
Professor of Medicine, Emerita
Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.
